A long‐acting pegylated recombinant human growth hormone (Jintrolong®) in healthy adult subjects: Two single‐dose trials evaluating safety, tolerability and pharmacokinetics.
Saved in:
| Title: | A long‐acting pegylated recombinant human growth hormone (Jintrolong®) in healthy adult subjects: Two single‐dose trials evaluating safety, tolerability and pharmacokinetics. |
|---|---|
| Authors: | Guan, Y.1, He, F.1,2, Wu, J.1, Zhao, L.1, Wang, X.1, Huang, L.1, Zeng, G.1, Ren, B.3, Chen, J.3, Liao, X.3, Ma, Z.3, Chen, X.3, Zhong, G.1 zhonggp@mail.sysu.edu.cn, Huang, M.1, Zhao, X.1 |
| Source: | Journal of Clinical Pharmacy & Therapeutics. Oct2018, Vol. 43 Issue 5, p640-646. 7p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 02694727 |
|---|---|
| DOI: | 10.1111/jcpt.12732 |
